These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17279346)

  • 1. SREBP-1c and TFE3, energy transcription factors that regulate hepatic insulin signaling.
    Shimano H
    J Mol Med (Berl); 2007 May; 85(5):437-44. PubMed ID: 17279346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterol regulatory element-binding protein-1c and pancreatic beta-cell dysfunction.
    Shimano H; Amemiya-Kudo M; Takahashi A; Kato T; Ishikawa M; Yamada N
    Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():133-9. PubMed ID: 17919187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice.
    Kammoun HL; Chabanon H; Hainault I; Luquet S; Magnan C; Koike T; Ferré P; Foufelle F
    J Clin Invest; 2009 May; 119(5):1201-15. PubMed ID: 19363290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
    Ferré P; Foufelle F
    Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipid synthetic transcription factor, SREBP].
    Hitoshi S
    Nihon Rinsho; 2005 May; 63(5):897-907. PubMed ID: 15881188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
    Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M
    Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxO1 inhibits sterol regulatory element-binding protein-1c (SREBP-1c) gene expression via transcription factors Sp1 and SREBP-1c.
    Deng X; Zhang W; O-Sullivan I; Williams JB; Dong Q; Park EA; Raghow R; Unterman TG; Elam MB
    J Biol Chem; 2012 Jun; 287(24):20132-43. PubMed ID: 22511764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic islets.
    Kato T; Shimano H; Yamamoto T; Ishikawa M; Kumadaki S; Matsuzaka T; Nakagawa Y; Yahagi N; Nakakuki M; Hasty AH; Takeuchi Y; Kobayashi K; Takahashi A; Yatoh S; Suzuki H; Sone H; Yamada N
    Diabetes; 2008 Sep; 57(9):2382-92. PubMed ID: 18458149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E4BP4 is an insulin-induced stabilizer of nuclear SREBP-1c and promotes SREBP-1c-mediated lipogenesis.
    Tong X; Li P; Zhang D; VanDommelen K; Gupta N; Rui L; Omary MB; Yin L
    J Lipid Res; 2016 Jul; 57(7):1219-30. PubMed ID: 27252523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
    Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.
    Yuan M; Pino E; Wu L; Kacergis M; Soukas AA
    J Biol Chem; 2012 Aug; 287(35):29579-88. PubMed ID: 22773877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP.
    Xu X; So JS; Park JG; Lee AH
    Semin Liver Dis; 2013 Nov; 33(4):301-11. PubMed ID: 24222088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice.
    Linden AG; Li S; Choi HY; Fang F; Fukasawa M; Uyeda K; Hammer RE; Horton JD; Engelking LJ; Liang G
    J Lipid Res; 2018 Mar; 59(3):475-487. PubMed ID: 29335275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes.
    Nakagawa Y; Shimano H; Yoshikawa T; Ide T; Tamura M; Furusawa M; Yamamoto T; Inoue N; Matsuzaka T; Takahashi A; Hasty AH; Suzuki H; Sone H; Toyoshima H; Yahagi N; Yamada N
    Nat Med; 2006 Jan; 12(1):107-13. PubMed ID: 16327801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role for sterol regulatory element binding protein-1c activation in mediating skeletal muscle insulin resistance via repression of rat insulin receptor substrate-1 transcription.
    Bi Y; Wu W; Shi J; Liang H; Yin W; Chen Y; Tang S; Cao S; Cai M; Shen S; Gao Q; Weng J; Zhu D
    Diabetologia; 2014 Mar; 57(3):592-602. PubMed ID: 24362725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver.
    Dentin R; Girard J; Postic C
    Biochimie; 2005 Jan; 87(1):81-6. PubMed ID: 15733741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase Cbeta mediates hepatic induction of sterol-regulatory element binding protein-1c by insulin.
    Yamamoto T; Watanabe K; Inoue N; Nakagawa Y; Ishigaki N; Matsuzaka T; Takeuchi Y; Kobayashi K; Yatoh S; Takahashi A; Suzuki H; Yahagi N; Gotoda T; Yamada N; Shimano H
    J Lipid Res; 2010 Jul; 51(7):1859-70. PubMed ID: 20179320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFkappaB) in liver of rodents used as a model of diabetes, and relationships to hyperlipidaemia and insulin resistance.
    Sajan MP; Standaert ML; Rivas J; Miura A; Kanoh Y; Soto J; Taniguchi CM; Kahn CR; Farese RV
    Diabetologia; 2009 Jun; 52(6):1197-207. PubMed ID: 19357831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F6P/G6P-mediated ChREBP activation promotes the insulin resistance-driven hepatic lipid deposition in zebrafish.
    Gong Y; Lu Q; Xi L; Liu Y; Yang B; Su J; Liu H; Jin J; Zhang Z; Yang Y; Zhu X; Xie S; Han D
    J Nutr Biochem; 2023 Dec; 122():109452. PubMed ID: 37748621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD.
    Du X; Cai C; Yao J; Zhou Y; Yu H; Shen W
    Biochem Biophys Res Commun; 2017 Jan; 483(1):409-417. PubMed ID: 28027934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.